GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Humedix Co Ltd (XKRX:200670) » Definitions » Debt-to-EBITDA

Humedix Co (XKRX:200670) Debt-to-EBITDA : 0.04 (As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Humedix Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Humedix Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩1,652 Mil. Humedix Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩1,305 Mil. Humedix Co's annualized EBITDA for the quarter that ended in Dec. 2024 was ₩73,637 Mil. Humedix Co's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2024 was 0.04.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Humedix Co's Debt-to-EBITDA or its related term are showing as below:

XKRX:200670' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.05   Med: 0.48   Max: 1.27
Current: 0.05

During the past 12 years, the highest Debt-to-EBITDA Ratio of Humedix Co was 1.27. The lowest was 0.05. And the median was 0.48.

XKRX:200670's Debt-to-EBITDA is ranked better than
92.14% of 674 companies
in the Drug Manufacturers industry
Industry Median: 1.67 vs XKRX:200670: 0.05

Humedix Co Debt-to-EBITDA Historical Data

The historical data trend for Humedix Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Humedix Co Debt-to-EBITDA Chart

Humedix Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.68 1.27 0.82 0.06 0.05

Humedix Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.05 0.04 0.04 0.04

Competitive Comparison of Humedix Co's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Humedix Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Humedix Co's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Humedix Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Humedix Co's Debt-to-EBITDA falls into.


;
;

Humedix Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Humedix Co's Debt-to-EBITDA for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1652.087 + 1304.905) / 59882.215
=0.05

Humedix Co's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1652.087 + 1304.905) / 73637.404
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2024) EBITDA data.


Humedix Co  (XKRX:200670) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Humedix Co Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Humedix Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Humedix Co Business Description

Traded in Other Exchanges
N/A
Address
268 Anyang Dongan Game Metallurgy, 502 Gwanyang-dong Anyang Mega Valley, Anyang, Gyeonggi, KOR, 431-809
Humedix Co Ltd is a cosmeceutical healthcare company. It supplies Hyaluronic Acid raw material medicine of low molecule and the high molecule which are used in arthritis medicine, eyedrops and in injections for ophthalmology. Further, it is dedicated to the development of new functional materials with diverse physiological activities including vitamin derivatives and supplies a variety of functional materials. In addition, it offers various medical devices, cosmetic and health functional foods. The business activities are primarily carried out through South Korea.

Humedix Co Headlines

No Headlines